全文获取类型
收费全文 | 1786篇 |
免费 | 87篇 |
国内免费 | 11篇 |
专业分类
耳鼻咽喉 | 19篇 |
儿科学 | 99篇 |
妇产科学 | 42篇 |
基础医学 | 198篇 |
口腔科学 | 67篇 |
临床医学 | 94篇 |
内科学 | 418篇 |
皮肤病学 | 56篇 |
神经病学 | 112篇 |
特种医学 | 183篇 |
外科学 | 183篇 |
综合类 | 17篇 |
预防医学 | 166篇 |
眼科学 | 22篇 |
药学 | 96篇 |
中国医学 | 3篇 |
肿瘤学 | 109篇 |
出版年
2023年 | 7篇 |
2022年 | 9篇 |
2021年 | 36篇 |
2020年 | 22篇 |
2019年 | 36篇 |
2018年 | 33篇 |
2017年 | 43篇 |
2016年 | 37篇 |
2015年 | 31篇 |
2014年 | 63篇 |
2013年 | 81篇 |
2012年 | 90篇 |
2011年 | 94篇 |
2010年 | 61篇 |
2009年 | 72篇 |
2008年 | 82篇 |
2007年 | 77篇 |
2006年 | 72篇 |
2005年 | 75篇 |
2004年 | 64篇 |
2003年 | 65篇 |
2002年 | 52篇 |
2001年 | 41篇 |
2000年 | 52篇 |
1999年 | 54篇 |
1998年 | 43篇 |
1997年 | 41篇 |
1996年 | 55篇 |
1995年 | 35篇 |
1994年 | 32篇 |
1993年 | 41篇 |
1992年 | 14篇 |
1991年 | 27篇 |
1990年 | 24篇 |
1989年 | 24篇 |
1988年 | 23篇 |
1987年 | 31篇 |
1986年 | 29篇 |
1985年 | 18篇 |
1984年 | 8篇 |
1983年 | 4篇 |
1982年 | 20篇 |
1981年 | 7篇 |
1980年 | 7篇 |
1979年 | 5篇 |
1977年 | 11篇 |
1976年 | 10篇 |
1975年 | 8篇 |
1972年 | 2篇 |
1971年 | 4篇 |
排序方式: 共有1884条查询结果,搜索用时 15 毫秒
31.
32.
F Hidalgo J De Castro R Servent A Alastrué M Rull D Casas J Albero J F Llamazares M Vilagrasa J A Salvá 《Revista española de enfermedades digestivas》1991,80(2):115-118
We present a patient affected of diverticular disease of the colon, with diverticulosis and two giant diverticula of the sigma, both located at the mesenteric edge. We would like to stress the low incidence of reports about this entity in the medical literature, its uncommon location and the fact of a double lesion coinciding in a single patient. We discuss the most important nosocomial aspects and the different diagnoses. Finally, we support the idea of distinguishing three different entities that in the medical literature are usually unified as a single "giant diverticulum of the colon". We reaffirm ourselves on the importance of an early diagnosis and a correct indication for surgery. 相似文献
33.
Casas M 《Health policy (Amsterdam, Netherlands)》1991,17(2):121-132
34.
35.
Higher fat and energy intakes confer a survival advantage in cystic fibrosis (CF). There is a need to develop effective nutrition programmes that ensure optimal energy intake in CF.
A cross-sectional measurement of clinical characteristics and energy and fat intakes in patients attending the CF outpatients clinic of the John Hunter Hospital, Newcastle was undertaken. Twenty-nine subjects, mean age 12 years (range 4.3–20.2), completed weighed food records to determine the contribution of fat to the percentage of the recommended energy intake obtained and to document use of pancreatic enzyme replacement therapy.
Diets with a high percentage of energy derived from fat did not guarantee that individuals with CF met their energy requirements. Subjects with total fat intakes of 100 g per day or greater, however, achieved in excess of 110% recommended daily intake (RDI) for energy. Up to 47% of subjects consumed more pancreatic enzyme replacement capsules than shown to give maximum effectiveness.
Setting a 100 g daily fat target is a realistic way of ensuring high energy intakes in CF. Fat ready reckoners would identify the fat content of food and prescribe specific numbers of pancreatic enzyme replacement capsules to be consumed with each meal or food item. 相似文献
Methodology:
A cross-sectional measurement of clinical characteristics and energy and fat intakes in patients attending the CF outpatients clinic of the John Hunter Hospital, Newcastle was undertaken. Twenty-nine subjects, mean age 12 years (range 4.3–20.2), completed weighed food records to determine the contribution of fat to the percentage of the recommended energy intake obtained and to document use of pancreatic enzyme replacement therapy.
Results:
Diets with a high percentage of energy derived from fat did not guarantee that individuals with CF met their energy requirements. Subjects with total fat intakes of 100 g per day or greater, however, achieved in excess of 110% recommended daily intake (RDI) for energy. Up to 47% of subjects consumed more pancreatic enzyme replacement capsules than shown to give maximum effectiveness.
Conclusion:
Setting a 100 g daily fat target is a realistic way of ensuring high energy intakes in CF. Fat ready reckoners would identify the fat content of food and prescribe specific numbers of pancreatic enzyme replacement capsules to be consumed with each meal or food item. 相似文献
36.
37.
Epidermal growth factor receptor (EGFR) in the prognosis of bladder carcinoma. Experience of 5 years
38.
39.
In a previous study we have shown that monoclonal antibody F1 (MoAb F1), directed against an epitope on the heavy chain of factor XII distinct from the binding site for anionic surfaces, is able to activate factor XII in plasma (Nuijens JH, et al: J Biol Chem 264; 12941, 1989). Here, we studied in detail the mechanism underlying the activation of factor XII by MoAb F1 using purified proteins. Formation of factor XIIa was assessed by measuring its amidolytic activity towards the chromogenic substrate H-D-Pro-Phe-Arg-pNA (S-2302) in the presence of soybean trypsin inhibitor and by assessing cleavage on sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE). Upon incubation with MoAb F1 alone, factor XII was auto-activated in a time-dependent fashion, activation being maximal after 30 hours. Factor XII incubated in the absence of MoAb F1 was hardly activated by kallikrein, whereas in the presence of MoAb F1, but not in that of a control MoAb, the rate of factor XII activation by kallikrein was promoted at least 60-fold. Maximal activation of factor XII with kallikrein in the presence of MoAb F1 was reached within 1 hour. This effect of kallikrein on the cleavage of factor XII bound to MoAb F1 was specific because the fibrinolytic enzymes plasmin, urokinase, and tissue-type plasminogen activator could not substitute for kallikrein. Also, trypsin could easily activate factor XII, but in contrast to kallikrein, this activation was independent of MoAb F1. SDS-PAGE analysis showed that the appearance of amidolytic activity correlated well with cleavage of factor XII. MoAb F1-induced activation of factor XII in this purified system was not dependent on the presence of high- molecular-weight kininogen (HK), in contrast to the activation of the contact system in plasma by MoAb F1. Experiments with deletion mutants revealed that the epitopic region for MoAb F1 on factor XII is located on the kringle domain. Thus, this study shows that binding of ligands to the kringle domain, which does not contribute to the proposed binding site for negatively charged surfaces, may induce activation of factor XII. Therefore, these findings point to the existence of multiple mechanisms of activation of factor XII. 相似文献
40.
Fernández-Rodriguez CM Gutiérrez ML Serrano PL Lledó JL Santander C Fernández TP Tomás E Cacho G Nevado M Casas ML 《Digestive diseases and sciences》2004,49(11-12):1971-1976
Alcohol consumption, age at infection, and male gender have been identified as risk factors for faster fibrosis progression in patients with chronic hepatitis C (CHC). Yet the influence of liver steatosis, light to moderate alcohol consumption, or iron overload on this progression remains controversial. To analyze the effect of individual risk factors and their interaction on fibrosis progression in a group of patients with CHC and a definite date of infection, we studied 133 consecutive untreated patients. Covariates included were age, body mass index (BMI), gender, age at infection, alcohol intake, serum lipids, glycemia, serum ALT, AST, GGT, iron, and ferritin, grade and stage (METAVIR and Scheuer), and hepatic stainable iron (Perl's stain). The rate of fibrosis progression was inferred from the METAVIR score. By logistic regression analysis, hepatic steatosis (odds ratio [OR], 3.035; 95% confidence interval [CI], 1.16-7.93), serum ferritin levels higher than 290 ng/ml (OR, 5.5; 1.6-18.65), and light to moderate ethanol intake (1-50 g/day) (OR, 5.22; 1.5-17.67) were independently associated with faster fibrosis progression. There was no effect of interaction between these variables on the rate of fibrosis progression. Liver steatosis, serum ferritin levels, and light to moderate alcohol intake are associated with faster fibrosis progression in chronic hepatitis C. Combination of these factors did not further accelerate this progression. The impact of modification of these factors on progression should be tested in longitudinal studies. 相似文献